Medical Care
Global Anti-tuberculosis Therapeutics Market Research Report 2025
- Sep 18, 25
- ID: 507552
- Pages: 85
- Figures: 88
- Views: 11
This report aims to provide a comprehensive presentation of the global market for Anti-tuberculosis Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-tuberculosis Therapeutics.
The Anti-tuberculosis Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Anti-tuberculosis Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anti-tuberculosis Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Lupin
Macleods Pharmaceuticals
Otsuka Pharmaceutical
Johnson & Johnson
Pfizer
Novartis
Abbott
AstraZeneca
Bayer
Eli Lilly
GlaxoSmithKline
Merck
Sanofi
Segment by Type
Isoniazid
Rifampin
Ethambutol
Pyrazinamide
Otherr
Segment by Application
Hospitals and Clinics
Government Agencies
Non-Profit Organizations
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Anti-tuberculosis Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The Anti-tuberculosis Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Anti-tuberculosis Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anti-tuberculosis Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Lupin
Macleods Pharmaceuticals
Otsuka Pharmaceutical
Johnson & Johnson
Pfizer
Novartis
Abbott
AstraZeneca
Bayer
Eli Lilly
GlaxoSmithKline
Merck
Sanofi
Segment by Type
Isoniazid
Rifampin
Ethambutol
Pyrazinamide
Otherr
Segment by Application
Hospitals and Clinics
Government Agencies
Non-Profit Organizations
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Anti-tuberculosis Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anti-tuberculosis Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Isoniazid
1.2.3 Rifampin
1.2.4 Ethambutol
1.2.5 Pyrazinamide
1.2.6 Otherr
1.3 Market by Application
1.3.1 Global Anti-tuberculosis Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals and Clinics
1.3.3 Government Agencies
1.3.4 Non-Profit Organizations
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Anti-tuberculosis Therapeutics Market Perspective (2020-2031)
2.2 Global Anti-tuberculosis Therapeutics Growth Trends by Region
2.2.1 Global Anti-tuberculosis Therapeutics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Anti-tuberculosis Therapeutics Historic Market Size by Region (2020-2025)
2.2.3 Anti-tuberculosis Therapeutics Forecasted Market Size by Region (2026-2031)
2.3 Anti-tuberculosis Therapeutics Market Dynamics
2.3.1 Anti-tuberculosis Therapeutics Industry Trends
2.3.2 Anti-tuberculosis Therapeutics Market Drivers
2.3.3 Anti-tuberculosis Therapeutics Market Challenges
2.3.4 Anti-tuberculosis Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Anti-tuberculosis Therapeutics Players by Revenue
3.1.1 Global Top Anti-tuberculosis Therapeutics Players by Revenue (2020-2025)
3.1.2 Global Anti-tuberculosis Therapeutics Revenue Market Share by Players (2020-2025)
3.2 Global Anti-tuberculosis Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Anti-tuberculosis Therapeutics Revenue
3.4 Global Anti-tuberculosis Therapeutics Market Concentration Ratio
3.4.1 Global Anti-tuberculosis Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anti-tuberculosis Therapeutics Revenue in 2024
3.5 Global Key Players of Anti-tuberculosis Therapeutics Head office and Area Served
3.6 Global Key Players of Anti-tuberculosis Therapeutics, Product and Application
3.7 Global Key Players of Anti-tuberculosis Therapeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Anti-tuberculosis Therapeutics Breakdown Data by Type
4.1 Global Anti-tuberculosis Therapeutics Historic Market Size by Type (2020-2025)
4.2 Global Anti-tuberculosis Therapeutics Forecasted Market Size by Type (2026-2031)
5 Anti-tuberculosis Therapeutics Breakdown Data by Application
5.1 Global Anti-tuberculosis Therapeutics Historic Market Size by Application (2020-2025)
5.2 Global Anti-tuberculosis Therapeutics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Anti-tuberculosis Therapeutics Market Size (2020-2031)
6.2 North America Anti-tuberculosis Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Anti-tuberculosis Therapeutics Market Size by Country (2020-2025)
6.4 North America Anti-tuberculosis Therapeutics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Anti-tuberculosis Therapeutics Market Size (2020-2031)
7.2 Europe Anti-tuberculosis Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Anti-tuberculosis Therapeutics Market Size by Country (2020-2025)
7.4 Europe Anti-tuberculosis Therapeutics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Anti-tuberculosis Therapeutics Market Size (2020-2031)
8.2 Asia-Pacific Anti-tuberculosis Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Anti-tuberculosis Therapeutics Market Size by Region (2020-2025)
8.4 Asia-Pacific Anti-tuberculosis Therapeutics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Anti-tuberculosis Therapeutics Market Size (2020-2031)
9.2 Latin America Anti-tuberculosis Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Anti-tuberculosis Therapeutics Market Size by Country (2020-2025)
9.4 Latin America Anti-tuberculosis Therapeutics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Anti-tuberculosis Therapeutics Market Size (2020-2031)
10.2 Middle East & Africa Anti-tuberculosis Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Anti-tuberculosis Therapeutics Market Size by Country (2020-2025)
10.4 Middle East & Africa Anti-tuberculosis Therapeutics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Lupin
11.1.1 Lupin Company Details
11.1.2 Lupin Business Overview
11.1.3 Lupin Anti-tuberculosis Therapeutics Introduction
11.1.4 Lupin Revenue in Anti-tuberculosis Therapeutics Business (2020-2025)
11.1.5 Lupin Recent Development
11.2 Macleods Pharmaceuticals
11.2.1 Macleods Pharmaceuticals Company Details
11.2.2 Macleods Pharmaceuticals Business Overview
11.2.3 Macleods Pharmaceuticals Anti-tuberculosis Therapeutics Introduction
11.2.4 Macleods Pharmaceuticals Revenue in Anti-tuberculosis Therapeutics Business (2020-2025)
11.2.5 Macleods Pharmaceuticals Recent Development
11.3 Otsuka Pharmaceutical
11.3.1 Otsuka Pharmaceutical Company Details
11.3.2 Otsuka Pharmaceutical Business Overview
11.3.3 Otsuka Pharmaceutical Anti-tuberculosis Therapeutics Introduction
11.3.4 Otsuka Pharmaceutical Revenue in Anti-tuberculosis Therapeutics Business (2020-2025)
11.3.5 Otsuka Pharmaceutical Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Anti-tuberculosis Therapeutics Introduction
11.4.4 Johnson & Johnson Revenue in Anti-tuberculosis Therapeutics Business (2020-2025)
11.4.5 Johnson & Johnson Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Anti-tuberculosis Therapeutics Introduction
11.5.4 Pfizer Revenue in Anti-tuberculosis Therapeutics Business (2020-2025)
11.5.5 Pfizer Recent Development
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis Anti-tuberculosis Therapeutics Introduction
11.6.4 Novartis Revenue in Anti-tuberculosis Therapeutics Business (2020-2025)
11.6.5 Novartis Recent Development
11.7 Abbott
11.7.1 Abbott Company Details
11.7.2 Abbott Business Overview
11.7.3 Abbott Anti-tuberculosis Therapeutics Introduction
11.7.4 Abbott Revenue in Anti-tuberculosis Therapeutics Business (2020-2025)
11.7.5 Abbott Recent Development
11.8 AstraZeneca
11.8.1 AstraZeneca Company Details
11.8.2 AstraZeneca Business Overview
11.8.3 AstraZeneca Anti-tuberculosis Therapeutics Introduction
11.8.4 AstraZeneca Revenue in Anti-tuberculosis Therapeutics Business (2020-2025)
11.8.5 AstraZeneca Recent Development
11.9 Bayer
11.9.1 Bayer Company Details
11.9.2 Bayer Business Overview
11.9.3 Bayer Anti-tuberculosis Therapeutics Introduction
11.9.4 Bayer Revenue in Anti-tuberculosis Therapeutics Business (2020-2025)
11.9.5 Bayer Recent Development
11.10 Eli Lilly
11.10.1 Eli Lilly Company Details
11.10.2 Eli Lilly Business Overview
11.10.3 Eli Lilly Anti-tuberculosis Therapeutics Introduction
11.10.4 Eli Lilly Revenue in Anti-tuberculosis Therapeutics Business (2020-2025)
11.10.5 Eli Lilly Recent Development
11.11 GlaxoSmithKline
11.11.1 GlaxoSmithKline Company Details
11.11.2 GlaxoSmithKline Business Overview
11.11.3 GlaxoSmithKline Anti-tuberculosis Therapeutics Introduction
11.11.4 GlaxoSmithKline Revenue in Anti-tuberculosis Therapeutics Business (2020-2025)
11.11.5 GlaxoSmithKline Recent Development
11.12 Merck
11.12.1 Merck Company Details
11.12.2 Merck Business Overview
11.12.3 Merck Anti-tuberculosis Therapeutics Introduction
11.12.4 Merck Revenue in Anti-tuberculosis Therapeutics Business (2020-2025)
11.12.5 Merck Recent Development
11.13 Sanofi
11.13.1 Sanofi Company Details
11.13.2 Sanofi Business Overview
11.13.3 Sanofi Anti-tuberculosis Therapeutics Introduction
11.13.4 Sanofi Revenue in Anti-tuberculosis Therapeutics Business (2020-2025)
11.13.5 Sanofi Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anti-tuberculosis Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Isoniazid
1.2.3 Rifampin
1.2.4 Ethambutol
1.2.5 Pyrazinamide
1.2.6 Otherr
1.3 Market by Application
1.3.1 Global Anti-tuberculosis Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals and Clinics
1.3.3 Government Agencies
1.3.4 Non-Profit Organizations
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Anti-tuberculosis Therapeutics Market Perspective (2020-2031)
2.2 Global Anti-tuberculosis Therapeutics Growth Trends by Region
2.2.1 Global Anti-tuberculosis Therapeutics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Anti-tuberculosis Therapeutics Historic Market Size by Region (2020-2025)
2.2.3 Anti-tuberculosis Therapeutics Forecasted Market Size by Region (2026-2031)
2.3 Anti-tuberculosis Therapeutics Market Dynamics
2.3.1 Anti-tuberculosis Therapeutics Industry Trends
2.3.2 Anti-tuberculosis Therapeutics Market Drivers
2.3.3 Anti-tuberculosis Therapeutics Market Challenges
2.3.4 Anti-tuberculosis Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Anti-tuberculosis Therapeutics Players by Revenue
3.1.1 Global Top Anti-tuberculosis Therapeutics Players by Revenue (2020-2025)
3.1.2 Global Anti-tuberculosis Therapeutics Revenue Market Share by Players (2020-2025)
3.2 Global Anti-tuberculosis Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Anti-tuberculosis Therapeutics Revenue
3.4 Global Anti-tuberculosis Therapeutics Market Concentration Ratio
3.4.1 Global Anti-tuberculosis Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anti-tuberculosis Therapeutics Revenue in 2024
3.5 Global Key Players of Anti-tuberculosis Therapeutics Head office and Area Served
3.6 Global Key Players of Anti-tuberculosis Therapeutics, Product and Application
3.7 Global Key Players of Anti-tuberculosis Therapeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Anti-tuberculosis Therapeutics Breakdown Data by Type
4.1 Global Anti-tuberculosis Therapeutics Historic Market Size by Type (2020-2025)
4.2 Global Anti-tuberculosis Therapeutics Forecasted Market Size by Type (2026-2031)
5 Anti-tuberculosis Therapeutics Breakdown Data by Application
5.1 Global Anti-tuberculosis Therapeutics Historic Market Size by Application (2020-2025)
5.2 Global Anti-tuberculosis Therapeutics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Anti-tuberculosis Therapeutics Market Size (2020-2031)
6.2 North America Anti-tuberculosis Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Anti-tuberculosis Therapeutics Market Size by Country (2020-2025)
6.4 North America Anti-tuberculosis Therapeutics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Anti-tuberculosis Therapeutics Market Size (2020-2031)
7.2 Europe Anti-tuberculosis Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Anti-tuberculosis Therapeutics Market Size by Country (2020-2025)
7.4 Europe Anti-tuberculosis Therapeutics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Anti-tuberculosis Therapeutics Market Size (2020-2031)
8.2 Asia-Pacific Anti-tuberculosis Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Anti-tuberculosis Therapeutics Market Size by Region (2020-2025)
8.4 Asia-Pacific Anti-tuberculosis Therapeutics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Anti-tuberculosis Therapeutics Market Size (2020-2031)
9.2 Latin America Anti-tuberculosis Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Anti-tuberculosis Therapeutics Market Size by Country (2020-2025)
9.4 Latin America Anti-tuberculosis Therapeutics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Anti-tuberculosis Therapeutics Market Size (2020-2031)
10.2 Middle East & Africa Anti-tuberculosis Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Anti-tuberculosis Therapeutics Market Size by Country (2020-2025)
10.4 Middle East & Africa Anti-tuberculosis Therapeutics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Lupin
11.1.1 Lupin Company Details
11.1.2 Lupin Business Overview
11.1.3 Lupin Anti-tuberculosis Therapeutics Introduction
11.1.4 Lupin Revenue in Anti-tuberculosis Therapeutics Business (2020-2025)
11.1.5 Lupin Recent Development
11.2 Macleods Pharmaceuticals
11.2.1 Macleods Pharmaceuticals Company Details
11.2.2 Macleods Pharmaceuticals Business Overview
11.2.3 Macleods Pharmaceuticals Anti-tuberculosis Therapeutics Introduction
11.2.4 Macleods Pharmaceuticals Revenue in Anti-tuberculosis Therapeutics Business (2020-2025)
11.2.5 Macleods Pharmaceuticals Recent Development
11.3 Otsuka Pharmaceutical
11.3.1 Otsuka Pharmaceutical Company Details
11.3.2 Otsuka Pharmaceutical Business Overview
11.3.3 Otsuka Pharmaceutical Anti-tuberculosis Therapeutics Introduction
11.3.4 Otsuka Pharmaceutical Revenue in Anti-tuberculosis Therapeutics Business (2020-2025)
11.3.5 Otsuka Pharmaceutical Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Anti-tuberculosis Therapeutics Introduction
11.4.4 Johnson & Johnson Revenue in Anti-tuberculosis Therapeutics Business (2020-2025)
11.4.5 Johnson & Johnson Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Anti-tuberculosis Therapeutics Introduction
11.5.4 Pfizer Revenue in Anti-tuberculosis Therapeutics Business (2020-2025)
11.5.5 Pfizer Recent Development
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis Anti-tuberculosis Therapeutics Introduction
11.6.4 Novartis Revenue in Anti-tuberculosis Therapeutics Business (2020-2025)
11.6.5 Novartis Recent Development
11.7 Abbott
11.7.1 Abbott Company Details
11.7.2 Abbott Business Overview
11.7.3 Abbott Anti-tuberculosis Therapeutics Introduction
11.7.4 Abbott Revenue in Anti-tuberculosis Therapeutics Business (2020-2025)
11.7.5 Abbott Recent Development
11.8 AstraZeneca
11.8.1 AstraZeneca Company Details
11.8.2 AstraZeneca Business Overview
11.8.3 AstraZeneca Anti-tuberculosis Therapeutics Introduction
11.8.4 AstraZeneca Revenue in Anti-tuberculosis Therapeutics Business (2020-2025)
11.8.5 AstraZeneca Recent Development
11.9 Bayer
11.9.1 Bayer Company Details
11.9.2 Bayer Business Overview
11.9.3 Bayer Anti-tuberculosis Therapeutics Introduction
11.9.4 Bayer Revenue in Anti-tuberculosis Therapeutics Business (2020-2025)
11.9.5 Bayer Recent Development
11.10 Eli Lilly
11.10.1 Eli Lilly Company Details
11.10.2 Eli Lilly Business Overview
11.10.3 Eli Lilly Anti-tuberculosis Therapeutics Introduction
11.10.4 Eli Lilly Revenue in Anti-tuberculosis Therapeutics Business (2020-2025)
11.10.5 Eli Lilly Recent Development
11.11 GlaxoSmithKline
11.11.1 GlaxoSmithKline Company Details
11.11.2 GlaxoSmithKline Business Overview
11.11.3 GlaxoSmithKline Anti-tuberculosis Therapeutics Introduction
11.11.4 GlaxoSmithKline Revenue in Anti-tuberculosis Therapeutics Business (2020-2025)
11.11.5 GlaxoSmithKline Recent Development
11.12 Merck
11.12.1 Merck Company Details
11.12.2 Merck Business Overview
11.12.3 Merck Anti-tuberculosis Therapeutics Introduction
11.12.4 Merck Revenue in Anti-tuberculosis Therapeutics Business (2020-2025)
11.12.5 Merck Recent Development
11.13 Sanofi
11.13.1 Sanofi Company Details
11.13.2 Sanofi Business Overview
11.13.3 Sanofi Anti-tuberculosis Therapeutics Introduction
11.13.4 Sanofi Revenue in Anti-tuberculosis Therapeutics Business (2020-2025)
11.13.5 Sanofi Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Anti-tuberculosis Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Isoniazid
Table 3. Key Players of Rifampin
Table 4. Key Players of Ethambutol
Table 5. Key Players of Pyrazinamide
Table 6. Key Players of Otherr
Table 7. Global Anti-tuberculosis Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Anti-tuberculosis Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Anti-tuberculosis Therapeutics Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Anti-tuberculosis Therapeutics Market Share by Region (2020-2025)
Table 11. Global Anti-tuberculosis Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Anti-tuberculosis Therapeutics Market Share by Region (2026-2031)
Table 13. Anti-tuberculosis Therapeutics Market Trends
Table 14. Anti-tuberculosis Therapeutics Market Drivers
Table 15. Anti-tuberculosis Therapeutics Market Challenges
Table 16. Anti-tuberculosis Therapeutics Market Restraints
Table 17. Global Anti-tuberculosis Therapeutics Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Anti-tuberculosis Therapeutics Market Share by Players (2020-2025)
Table 19. Global Top Anti-tuberculosis Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-tuberculosis Therapeutics as of 2024)
Table 20. Ranking of Global Top Anti-tuberculosis Therapeutics Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Anti-tuberculosis Therapeutics Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Anti-tuberculosis Therapeutics, Headquarters and Area Served
Table 23. Global Key Players of Anti-tuberculosis Therapeutics, Product and Application
Table 24. Global Key Players of Anti-tuberculosis Therapeutics, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Anti-tuberculosis Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Anti-tuberculosis Therapeutics Revenue Market Share by Type (2020-2025)
Table 28. Global Anti-tuberculosis Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Anti-tuberculosis Therapeutics Revenue Market Share by Type (2026-2031)
Table 30. Global Anti-tuberculosis Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Anti-tuberculosis Therapeutics Revenue Market Share by Application (2020-2025)
Table 32. Global Anti-tuberculosis Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Anti-tuberculosis Therapeutics Revenue Market Share by Application (2026-2031)
Table 34. North America Anti-tuberculosis Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Anti-tuberculosis Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Anti-tuberculosis Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Anti-tuberculosis Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Anti-tuberculosis Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Anti-tuberculosis Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Anti-tuberculosis Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Anti-tuberculosis Therapeutics Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Anti-tuberculosis Therapeutics Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Anti-tuberculosis Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Anti-tuberculosis Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Anti-tuberculosis Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Anti-tuberculosis Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Anti-tuberculosis Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Anti-tuberculosis Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 49. Lupin Company Details
Table 50. Lupin Business Overview
Table 51. Lupin Anti-tuberculosis Therapeutics Product
Table 52. Lupin Revenue in Anti-tuberculosis Therapeutics Business (2020-2025) & (US$ Million)
Table 53. Lupin Recent Development
Table 54. Macleods Pharmaceuticals Company Details
Table 55. Macleods Pharmaceuticals Business Overview
Table 56. Macleods Pharmaceuticals Anti-tuberculosis Therapeutics Product
Table 57. Macleods Pharmaceuticals Revenue in Anti-tuberculosis Therapeutics Business (2020-2025) & (US$ Million)
Table 58. Macleods Pharmaceuticals Recent Development
Table 59. Otsuka Pharmaceutical Company Details
Table 60. Otsuka Pharmaceutical Business Overview
Table 61. Otsuka Pharmaceutical Anti-tuberculosis Therapeutics Product
Table 62. Otsuka Pharmaceutical Revenue in Anti-tuberculosis Therapeutics Business (2020-2025) & (US$ Million)
Table 63. Otsuka Pharmaceutical Recent Development
Table 64. Johnson & Johnson Company Details
Table 65. Johnson & Johnson Business Overview
Table 66. Johnson & Johnson Anti-tuberculosis Therapeutics Product
Table 67. Johnson & Johnson Revenue in Anti-tuberculosis Therapeutics Business (2020-2025) & (US$ Million)
Table 68. Johnson & Johnson Recent Development
Table 69. Pfizer Company Details
Table 70. Pfizer Business Overview
Table 71. Pfizer Anti-tuberculosis Therapeutics Product
Table 72. Pfizer Revenue in Anti-tuberculosis Therapeutics Business (2020-2025) & (US$ Million)
Table 73. Pfizer Recent Development
Table 74. Novartis Company Details
Table 75. Novartis Business Overview
Table 76. Novartis Anti-tuberculosis Therapeutics Product
Table 77. Novartis Revenue in Anti-tuberculosis Therapeutics Business (2020-2025) & (US$ Million)
Table 78. Novartis Recent Development
Table 79. Abbott Company Details
Table 80. Abbott Business Overview
Table 81. Abbott Anti-tuberculosis Therapeutics Product
Table 82. Abbott Revenue in Anti-tuberculosis Therapeutics Business (2020-2025) & (US$ Million)
Table 83. Abbott Recent Development
Table 84. AstraZeneca Company Details
Table 85. AstraZeneca Business Overview
Table 86. AstraZeneca Anti-tuberculosis Therapeutics Product
Table 87. AstraZeneca Revenue in Anti-tuberculosis Therapeutics Business (2020-2025) & (US$ Million)
Table 88. AstraZeneca Recent Development
Table 89. Bayer Company Details
Table 90. Bayer Business Overview
Table 91. Bayer Anti-tuberculosis Therapeutics Product
Table 92. Bayer Revenue in Anti-tuberculosis Therapeutics Business (2020-2025) & (US$ Million)
Table 93. Bayer Recent Development
Table 94. Eli Lilly Company Details
Table 95. Eli Lilly Business Overview
Table 96. Eli Lilly Anti-tuberculosis Therapeutics Product
Table 97. Eli Lilly Revenue in Anti-tuberculosis Therapeutics Business (2020-2025) & (US$ Million)
Table 98. Eli Lilly Recent Development
Table 99. GlaxoSmithKline Company Details
Table 100. GlaxoSmithKline Business Overview
Table 101. GlaxoSmithKline Anti-tuberculosis Therapeutics Product
Table 102. GlaxoSmithKline Revenue in Anti-tuberculosis Therapeutics Business (2020-2025) & (US$ Million)
Table 103. GlaxoSmithKline Recent Development
Table 104. Merck Company Details
Table 105. Merck Business Overview
Table 106. Merck Anti-tuberculosis Therapeutics Product
Table 107. Merck Revenue in Anti-tuberculosis Therapeutics Business (2020-2025) & (US$ Million)
Table 108. Merck Recent Development
Table 109. Sanofi Company Details
Table 110. Sanofi Business Overview
Table 111. Sanofi Anti-tuberculosis Therapeutics Product
Table 112. Sanofi Revenue in Anti-tuberculosis Therapeutics Business (2020-2025) & (US$ Million)
Table 113. Sanofi Recent Development
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
Table 117. Authors List of This Report
List of Figures
Figure 1. Anti-tuberculosis Therapeutics Picture
Figure 2. Global Anti-tuberculosis Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Anti-tuberculosis Therapeutics Market Share by Type: 2024 VS 2031
Figure 4. Isoniazid Features
Figure 5. Rifampin Features
Figure 6. Ethambutol Features
Figure 7. Pyrazinamide Features
Figure 8. Otherr Features
Figure 9. Global Anti-tuberculosis Therapeutics Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Anti-tuberculosis Therapeutics Market Share by Application: 2024 VS 2031
Figure 11. Hospitals and Clinics Case Studies
Figure 12. Government Agencies Case Studies
Figure 13. Non-Profit Organizations Case Studies
Figure 14. Others Case Studies
Figure 15. Anti-tuberculosis Therapeutics Report Years Considered
Figure 16. Global Anti-tuberculosis Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 17. Global Anti-tuberculosis Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 18. Global Anti-tuberculosis Therapeutics Market Share by Region: 2024 VS 2031
Figure 19. Global Anti-tuberculosis Therapeutics Market Share by Players in 2024
Figure 20. Global Top Anti-tuberculosis Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-tuberculosis Therapeutics as of 2024)
Figure 21. The Top 10 and 5 Players Market Share by Anti-tuberculosis Therapeutics Revenue in 2024
Figure 22. North America Anti-tuberculosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. North America Anti-tuberculosis Therapeutics Market Share by Country (2020-2031)
Figure 24. United States Anti-tuberculosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Canada Anti-tuberculosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Anti-tuberculosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Europe Anti-tuberculosis Therapeutics Market Share by Country (2020-2031)
Figure 28. Germany Anti-tuberculosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. France Anti-tuberculosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. U.K. Anti-tuberculosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Italy Anti-tuberculosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Russia Anti-tuberculosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Nordic Countries Anti-tuberculosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Anti-tuberculosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Asia-Pacific Anti-tuberculosis Therapeutics Market Share by Region (2020-2031)
Figure 36. China Anti-tuberculosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Japan Anti-tuberculosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. South Korea Anti-tuberculosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Southeast Asia Anti-tuberculosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. India Anti-tuberculosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Australia Anti-tuberculosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Anti-tuberculosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Latin America Anti-tuberculosis Therapeutics Market Share by Country (2020-2031)
Figure 44. Mexico Anti-tuberculosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Brazil Anti-tuberculosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Anti-tuberculosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Middle East & Africa Anti-tuberculosis Therapeutics Market Share by Country (2020-2031)
Figure 48. Turkey Anti-tuberculosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia Anti-tuberculosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. UAE Anti-tuberculosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Lupin Revenue Growth Rate in Anti-tuberculosis Therapeutics Business (2020-2025)
Figure 52. Macleods Pharmaceuticals Revenue Growth Rate in Anti-tuberculosis Therapeutics Business (2020-2025)
Figure 53. Otsuka Pharmaceutical Revenue Growth Rate in Anti-tuberculosis Therapeutics Business (2020-2025)
Figure 54. Johnson & Johnson Revenue Growth Rate in Anti-tuberculosis Therapeutics Business (2020-2025)
Figure 55. Pfizer Revenue Growth Rate in Anti-tuberculosis Therapeutics Business (2020-2025)
Figure 56. Novartis Revenue Growth Rate in Anti-tuberculosis Therapeutics Business (2020-2025)
Figure 57. Abbott Revenue Growth Rate in Anti-tuberculosis Therapeutics Business (2020-2025)
Figure 58. AstraZeneca Revenue Growth Rate in Anti-tuberculosis Therapeutics Business (2020-2025)
Figure 59. Bayer Revenue Growth Rate in Anti-tuberculosis Therapeutics Business (2020-2025)
Figure 60. Eli Lilly Revenue Growth Rate in Anti-tuberculosis Therapeutics Business (2020-2025)
Figure 61. GlaxoSmithKline Revenue Growth Rate in Anti-tuberculosis Therapeutics Business (2020-2025)
Figure 62. Merck Revenue Growth Rate in Anti-tuberculosis Therapeutics Business (2020-2025)
Figure 63. Sanofi Revenue Growth Rate in Anti-tuberculosis Therapeutics Business (2020-2025)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Table 1. Global Anti-tuberculosis Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Isoniazid
Table 3. Key Players of Rifampin
Table 4. Key Players of Ethambutol
Table 5. Key Players of Pyrazinamide
Table 6. Key Players of Otherr
Table 7. Global Anti-tuberculosis Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Anti-tuberculosis Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Anti-tuberculosis Therapeutics Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Anti-tuberculosis Therapeutics Market Share by Region (2020-2025)
Table 11. Global Anti-tuberculosis Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Anti-tuberculosis Therapeutics Market Share by Region (2026-2031)
Table 13. Anti-tuberculosis Therapeutics Market Trends
Table 14. Anti-tuberculosis Therapeutics Market Drivers
Table 15. Anti-tuberculosis Therapeutics Market Challenges
Table 16. Anti-tuberculosis Therapeutics Market Restraints
Table 17. Global Anti-tuberculosis Therapeutics Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Anti-tuberculosis Therapeutics Market Share by Players (2020-2025)
Table 19. Global Top Anti-tuberculosis Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-tuberculosis Therapeutics as of 2024)
Table 20. Ranking of Global Top Anti-tuberculosis Therapeutics Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Anti-tuberculosis Therapeutics Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Anti-tuberculosis Therapeutics, Headquarters and Area Served
Table 23. Global Key Players of Anti-tuberculosis Therapeutics, Product and Application
Table 24. Global Key Players of Anti-tuberculosis Therapeutics, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Anti-tuberculosis Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Anti-tuberculosis Therapeutics Revenue Market Share by Type (2020-2025)
Table 28. Global Anti-tuberculosis Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Anti-tuberculosis Therapeutics Revenue Market Share by Type (2026-2031)
Table 30. Global Anti-tuberculosis Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Anti-tuberculosis Therapeutics Revenue Market Share by Application (2020-2025)
Table 32. Global Anti-tuberculosis Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Anti-tuberculosis Therapeutics Revenue Market Share by Application (2026-2031)
Table 34. North America Anti-tuberculosis Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Anti-tuberculosis Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Anti-tuberculosis Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Anti-tuberculosis Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Anti-tuberculosis Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Anti-tuberculosis Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Anti-tuberculosis Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Anti-tuberculosis Therapeutics Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Anti-tuberculosis Therapeutics Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Anti-tuberculosis Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Anti-tuberculosis Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Anti-tuberculosis Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Anti-tuberculosis Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Anti-tuberculosis Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Anti-tuberculosis Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 49. Lupin Company Details
Table 50. Lupin Business Overview
Table 51. Lupin Anti-tuberculosis Therapeutics Product
Table 52. Lupin Revenue in Anti-tuberculosis Therapeutics Business (2020-2025) & (US$ Million)
Table 53. Lupin Recent Development
Table 54. Macleods Pharmaceuticals Company Details
Table 55. Macleods Pharmaceuticals Business Overview
Table 56. Macleods Pharmaceuticals Anti-tuberculosis Therapeutics Product
Table 57. Macleods Pharmaceuticals Revenue in Anti-tuberculosis Therapeutics Business (2020-2025) & (US$ Million)
Table 58. Macleods Pharmaceuticals Recent Development
Table 59. Otsuka Pharmaceutical Company Details
Table 60. Otsuka Pharmaceutical Business Overview
Table 61. Otsuka Pharmaceutical Anti-tuberculosis Therapeutics Product
Table 62. Otsuka Pharmaceutical Revenue in Anti-tuberculosis Therapeutics Business (2020-2025) & (US$ Million)
Table 63. Otsuka Pharmaceutical Recent Development
Table 64. Johnson & Johnson Company Details
Table 65. Johnson & Johnson Business Overview
Table 66. Johnson & Johnson Anti-tuberculosis Therapeutics Product
Table 67. Johnson & Johnson Revenue in Anti-tuberculosis Therapeutics Business (2020-2025) & (US$ Million)
Table 68. Johnson & Johnson Recent Development
Table 69. Pfizer Company Details
Table 70. Pfizer Business Overview
Table 71. Pfizer Anti-tuberculosis Therapeutics Product
Table 72. Pfizer Revenue in Anti-tuberculosis Therapeutics Business (2020-2025) & (US$ Million)
Table 73. Pfizer Recent Development
Table 74. Novartis Company Details
Table 75. Novartis Business Overview
Table 76. Novartis Anti-tuberculosis Therapeutics Product
Table 77. Novartis Revenue in Anti-tuberculosis Therapeutics Business (2020-2025) & (US$ Million)
Table 78. Novartis Recent Development
Table 79. Abbott Company Details
Table 80. Abbott Business Overview
Table 81. Abbott Anti-tuberculosis Therapeutics Product
Table 82. Abbott Revenue in Anti-tuberculosis Therapeutics Business (2020-2025) & (US$ Million)
Table 83. Abbott Recent Development
Table 84. AstraZeneca Company Details
Table 85. AstraZeneca Business Overview
Table 86. AstraZeneca Anti-tuberculosis Therapeutics Product
Table 87. AstraZeneca Revenue in Anti-tuberculosis Therapeutics Business (2020-2025) & (US$ Million)
Table 88. AstraZeneca Recent Development
Table 89. Bayer Company Details
Table 90. Bayer Business Overview
Table 91. Bayer Anti-tuberculosis Therapeutics Product
Table 92. Bayer Revenue in Anti-tuberculosis Therapeutics Business (2020-2025) & (US$ Million)
Table 93. Bayer Recent Development
Table 94. Eli Lilly Company Details
Table 95. Eli Lilly Business Overview
Table 96. Eli Lilly Anti-tuberculosis Therapeutics Product
Table 97. Eli Lilly Revenue in Anti-tuberculosis Therapeutics Business (2020-2025) & (US$ Million)
Table 98. Eli Lilly Recent Development
Table 99. GlaxoSmithKline Company Details
Table 100. GlaxoSmithKline Business Overview
Table 101. GlaxoSmithKline Anti-tuberculosis Therapeutics Product
Table 102. GlaxoSmithKline Revenue in Anti-tuberculosis Therapeutics Business (2020-2025) & (US$ Million)
Table 103. GlaxoSmithKline Recent Development
Table 104. Merck Company Details
Table 105. Merck Business Overview
Table 106. Merck Anti-tuberculosis Therapeutics Product
Table 107. Merck Revenue in Anti-tuberculosis Therapeutics Business (2020-2025) & (US$ Million)
Table 108. Merck Recent Development
Table 109. Sanofi Company Details
Table 110. Sanofi Business Overview
Table 111. Sanofi Anti-tuberculosis Therapeutics Product
Table 112. Sanofi Revenue in Anti-tuberculosis Therapeutics Business (2020-2025) & (US$ Million)
Table 113. Sanofi Recent Development
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
Table 117. Authors List of This Report
List of Figures
Figure 1. Anti-tuberculosis Therapeutics Picture
Figure 2. Global Anti-tuberculosis Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Anti-tuberculosis Therapeutics Market Share by Type: 2024 VS 2031
Figure 4. Isoniazid Features
Figure 5. Rifampin Features
Figure 6. Ethambutol Features
Figure 7. Pyrazinamide Features
Figure 8. Otherr Features
Figure 9. Global Anti-tuberculosis Therapeutics Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Anti-tuberculosis Therapeutics Market Share by Application: 2024 VS 2031
Figure 11. Hospitals and Clinics Case Studies
Figure 12. Government Agencies Case Studies
Figure 13. Non-Profit Organizations Case Studies
Figure 14. Others Case Studies
Figure 15. Anti-tuberculosis Therapeutics Report Years Considered
Figure 16. Global Anti-tuberculosis Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 17. Global Anti-tuberculosis Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 18. Global Anti-tuberculosis Therapeutics Market Share by Region: 2024 VS 2031
Figure 19. Global Anti-tuberculosis Therapeutics Market Share by Players in 2024
Figure 20. Global Top Anti-tuberculosis Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-tuberculosis Therapeutics as of 2024)
Figure 21. The Top 10 and 5 Players Market Share by Anti-tuberculosis Therapeutics Revenue in 2024
Figure 22. North America Anti-tuberculosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. North America Anti-tuberculosis Therapeutics Market Share by Country (2020-2031)
Figure 24. United States Anti-tuberculosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Canada Anti-tuberculosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Anti-tuberculosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Europe Anti-tuberculosis Therapeutics Market Share by Country (2020-2031)
Figure 28. Germany Anti-tuberculosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. France Anti-tuberculosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. U.K. Anti-tuberculosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Italy Anti-tuberculosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Russia Anti-tuberculosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Nordic Countries Anti-tuberculosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Anti-tuberculosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Asia-Pacific Anti-tuberculosis Therapeutics Market Share by Region (2020-2031)
Figure 36. China Anti-tuberculosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Japan Anti-tuberculosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. South Korea Anti-tuberculosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Southeast Asia Anti-tuberculosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. India Anti-tuberculosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Australia Anti-tuberculosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Anti-tuberculosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Latin America Anti-tuberculosis Therapeutics Market Share by Country (2020-2031)
Figure 44. Mexico Anti-tuberculosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Brazil Anti-tuberculosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Anti-tuberculosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Middle East & Africa Anti-tuberculosis Therapeutics Market Share by Country (2020-2031)
Figure 48. Turkey Anti-tuberculosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia Anti-tuberculosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. UAE Anti-tuberculosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Lupin Revenue Growth Rate in Anti-tuberculosis Therapeutics Business (2020-2025)
Figure 52. Macleods Pharmaceuticals Revenue Growth Rate in Anti-tuberculosis Therapeutics Business (2020-2025)
Figure 53. Otsuka Pharmaceutical Revenue Growth Rate in Anti-tuberculosis Therapeutics Business (2020-2025)
Figure 54. Johnson & Johnson Revenue Growth Rate in Anti-tuberculosis Therapeutics Business (2020-2025)
Figure 55. Pfizer Revenue Growth Rate in Anti-tuberculosis Therapeutics Business (2020-2025)
Figure 56. Novartis Revenue Growth Rate in Anti-tuberculosis Therapeutics Business (2020-2025)
Figure 57. Abbott Revenue Growth Rate in Anti-tuberculosis Therapeutics Business (2020-2025)
Figure 58. AstraZeneca Revenue Growth Rate in Anti-tuberculosis Therapeutics Business (2020-2025)
Figure 59. Bayer Revenue Growth Rate in Anti-tuberculosis Therapeutics Business (2020-2025)
Figure 60. Eli Lilly Revenue Growth Rate in Anti-tuberculosis Therapeutics Business (2020-2025)
Figure 61. GlaxoSmithKline Revenue Growth Rate in Anti-tuberculosis Therapeutics Business (2020-2025)
Figure 62. Merck Revenue Growth Rate in Anti-tuberculosis Therapeutics Business (2020-2025)
Figure 63. Sanofi Revenue Growth Rate in Anti-tuberculosis Therapeutics Business (2020-2025)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global UV Delayed Curing Adhesives Market Outlook, In‑Depth Analysis & Forecast to 2031
Nov 04, 25
Global Die-Casting Die Steel Market Outlook, In‑Depth Analysis & Forecast to 2031
Nov 04, 25
Global Adaptive Neuromodulation Therapy Devices Market Outlook, In‑Depth Analysis & Forecast to 2031
Nov 04, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232